OVID
NASDAQ · Biotechnology
Ovid Therapeutics Inc
$2.78
+0.10 (+3.73%)
Open$2.70
Previous Close$2.68
Day High$2.80
Day Low$2.70
52W High$3.11
52W Low$0.32
Volume—
Avg Volume5.57M
Market Cap502.06M
P/E Ratio—
EPS$-0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+1,376.3% upside
Current
$2.78
$2.78
Target
$41.04
$41.04
$30.97
$41.04 avg
$66.83
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.77M | 10.51M | 31.11M |
| Net Income | -42,657,201 | -22,704,761 | -8,350,078 |
| Profit Margin | -240.1% | -228.1% | -26.8% |
| EBITDA | -103,283,885 | -58,028,086 | -13,566,183 |
| Free Cash Flow | — | — | -8,976,737 |
| Rev Growth | +69.1% | +69.1% | +19.5% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |